Episode Details
Back to Episodes
New Drug Combo Improves Skin Cancer Survival, CAR T Therapy Shrinks Brain Tumors, FDA Approves Moderna's mNEXSPIKE Vaccine, Vepdegestrant Doubles Survival in Trials, and more...
Published 1 year, 1 month ago
Description
(0:10): New Drug Combo Boosts Survival in Advanced Skin Cancer, Promising Future Treatment Shift
(2:20): Promising Dual-Target CAR T Therapy Shrinks Tumors in Aggressive Brain Cancer, Extends Survival
(4:30): FDA Approves Moderna's mNEXSPIKE for High-Risk Groups, Shifts Vaccine Strategy
(7:00): New Drug Vepdegestrant Doubles Progression-Free Survival in Breast Cancer Trial
(9:45): Revolutionary Infrared Contact Lenses Let Humans See in the Dark
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: MedpageToday
(2:20): Promising Dual-Target CAR T Therapy Shrinks Tumors in Aggressive Brain Cancer, Extends Survival
(4:30): FDA Approves Moderna's mNEXSPIKE for High-Risk Groups, Shifts Vaccine Strategy
(7:00): New Drug Vepdegestrant Doubles Progression-Free Survival in Breast Cancer Trial
(9:45): Revolutionary Infrared Contact Lenses Let Humans See in the Dark
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: MedpageToday